Trump administration decision could lead to higher drug premiums for millions of older adults
Adobe
John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07.
WASHINGTON — The Trump administration will end subsidies for private Medicare drug plans, likely resulting in higher premiums for some older adults right before the midterm elections.
Democrats were already campaigning on the approximately $1 trillion in health care cuts in Republicans’ tax bill from last summer. They immediately seized on the decision to end drug plan subsidies as another opportunity to attack Republicans on affordability.
